What is LeafWorks?
LeafWorks operates at the intersection of biotechnology and agricultural science, specializing in comprehensive genetic testing services. The company provides essential tools such as DNA sex testing, pathogen identification, and feminized seed certification, which are vital for maintaining quality control in modern breeding programs. By offering expert consulting alongside its laboratory services, LeafWorks enables stakeholders in the natural products sector to mitigate risk and ensure the authenticity of their botanical assets. Their commitment to modern breeding techniques and rigorous testing standards positions them as a trusted partner for cultivators and manufacturers seeking to optimize plant quality and supply chain integrity.
How much funding has LeafWorks raised?
LeafWorks has raised a total of $1.9M across 3 funding rounds:
Series A
$1M
Stock/Share Issuance
$700K
Stock/Share Issuance
$200K
Series A (2020): $1M with participation from Bonaventure Equity LLC
Stock/Share Issuance (2026): $700K, investors not publicly disclosed
Stock/Share Issuance (2026): $200K, investors not publicly disclosed
Key Investors in LeafWorks
Bonaventure Equity LLC
A venture capital firm specializing in early-stage investments within the cannabis and hemp sectors, focusing on companies that provide critical infrastructure and technology.
Undisclosed Investor
Undisclosed investor participating in the funding round.
Undisclosed Investor
Undisclosed investor participating in the funding round.
What's next for LeafWorks?
With the successful closure of this major strategic investment, LeafWorks is well-positioned to scale its laboratory capacity and expand its service offerings into emerging botanical markets. The company's strategic roadmap likely involves deepening its footprint in the functional mushroom space and enhancing its digital certification platforms to meet increasing regulatory demands for transparency. As the industry matures, LeafWorks' focus on data-driven genetic insights will be instrumental in setting new benchmarks for quality assurance. Investors and industry analysts will be monitoring the firm's ability to integrate these new resources into its core operations, potentially driving further consolidation of its market share in the botanical genomics landscape.
See full LeafWorks company page
